Explanatory Variables | TC ≥ 200 mg/dL AOR (95 % CI) | LDL-c ≥ 130 mg/dL AOR (95 % CI) | HDL-c < 40 mg/dL AOR (95 % CI) | TG ≥ 150 mg/dL AOR (95 % CI) | TC/HDL-c ≥ 5 AOR (95 % CI) |
---|---|---|---|---|---|
Antiretroviral therapy | Â | Â | Â | Â | Â |
 HAART-naïve* | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
 HAART treated | 6.24 (2.33-17.45) | 5.28 (1.17-16.32) | 1.07 (0.37-3.05) | 0.86 (0.32-2.28) | 2.51 (0.64-9.89) |
 p-value | < 0.001 | 0.004 | 0.904 | 0.762 | 0.188 |
Gender | Â | Â | Â | Â | Â |
 Male* | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
 Female | 2.17 (0.99-4.74) | 1.20 (0.55-2.65) | 0.45 (0.19-1.07) | 0.44 (0.19-1.01) | 0.42 (0.16-1.09) |
 p-value | 0.053 | 0.645 | 0.071 | 0.054 | 0.076 |
Age group | Â | Â | Â | Â | Â |
  ≤ 40 years* | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
  > 40 years | 1.11 (0.58-2.31) | 0.91 (0.47-1.78) | 0.80 (0.35-1.84) | 1.22 (0.57-2.58) | 1.02 (0.42-2.46) |
 p-value | 0.746 | 0.789 | 0.605 | 0.611 | 0.963 |
Body Mass Index | Â | Â | Â | Â | Â |
 BMI < 25 kg/m2* | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
 BMI ≥ 25 kg/m2 | 0.98 (0.52-1.86) | 1.07 (0.56-2.05) | 0.88 (0.39-1.98) | 3.25 (1.44-7.34) | 2.19 (0.87-5.51) |
 p-value | 0.962 | 0.845 | 0.757 | 0.005 | 0.097 |
HIV duration | Â | Â | Â | Â | Â |
  < 42 months* | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
  ≥ 42 months | 2.26 (1.16-4.42) | 1.71 (0.85-3.45) | 1.32 (0.53-3.29) | 1.89 (0.81-4.41) | 1.58 (0.60-4.13) |
 p-value | 0.017 | 0.133 | 0.0.545 | 0.140 | 0.350 |